Co-Authors
This is a "connection" page, showing publications co-authored by Ravindra Ganesh and Jordan Rosedahl.
Connection Strength
0.302
-
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
Score: 0.244
-
Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211019282.
Score: 0.058